Record ID: MS-N059 · Family: Acupuncture / symptom support · Clinical question: In adults with breast cancer who have persistent fatigue after chemotherapy, does acupuncture reduce fatigue?

Evidence label: Promising but inconsistent; a pragmatic benefit was not confirmed in a smaller sham-controlled trial.

Evidence at a glance

• Benefit: A 302-person pragmatic trial reported less fatigue with weekly acupuncture than usual care after six weeks.
• Certainty: Low to moderate. Results depend on the comparator; sham-controlled evidence is less convincing, and reviews report substantial heterogeneity.
• Risk: Usually mild when sterile single-use needles are used by a qualified practitioner; bruising, bleeding, faintness and infection are possible.
• Cancer control: Not studied.

What was studied

The largest trial randomized 302 people with breast cancer and persistent fatigue after chemotherapy to six weekly acupuncture sessions (227) or enhanced usual care (75). Complete six-week outcome data were available for 246 participants. Fatigue was the primary clinical target; the study was not designed to test cancer outcomes.

A separate sham-controlled post-chemotherapy trial and systematic reviews were also checked to place the pragmatic result in context.

What the results show

At six weeks, the pragmatic trial’s adjusted between-group difference on the Multidimensional Fatigue Inventory general-fatigue subscale was −3.11 points (95% CI −3.97 to −2.25; P<.001) in favor of acupuncture. Several related fatigue and quality-of-life measures also favored acupuncture.

That result does not settle how much benefit comes from needling itself, attention, expectation or other contextual effects. In the smaller sham-controlled trial, the between-group Brief Fatigue Inventory effect was 0.04 points (95% CI −0.57 to 0.66; P=.90). A recent meta-analysis pooled four studies (363 participants) and reported a mean difference of −5.50, but heterogeneity was high (I²=87%).

Limits and uncertainty

The largest study was pragmatic, unblinded and used usual care rather than a credible sham. The negative sham comparison was smaller. Review estimates combine different acupuncture protocols, fatigue measures and time points. A statistically significant average does not by itself establish a clinically important benefit for every patient. Funding and conflicts were reported in the individual publications; no independent verification beyond the checked reports was performed.

Safety and practical context

Discuss acupuncture with the oncology team when platelet or neutrophil counts are low, when taking anticoagulants, or when there is active infection, fragile skin, an indwelling device, bone involvement, or lymphedema risk. Needles should not be placed through infected or irradiated skin. Acupuncture is an adjunct to a fatigue assessment—not a substitute for checking anemia, thyroid dysfunction, sleep disturbance, depression, pain, medication effects or cancer progression.

Questions for the care team

• Have reversible causes of fatigue been assessed?
• Is there a qualified practitioner experienced in oncology and infection precautions?
• How will benefit be measured, and when should treatment stop if it is not helping?

Sources checked

• Molassiotis et al. randomized trial (PMID 23109700; DOI 10.1200/JCO.2012.41.6222)
• Systematic review of randomized trials (PMCID PMC7533944)
• ASCO–SIO fatigue guideline
• NCI PDQ acupuncture summary

Last literature search: October 18, 2026 · Record appraisal: October 18, 2026

Educational evidence summary, not personal medical advice. This record concerns symptom or supportive care. It does not establish tumor shrinkage, recurrence prevention or longer survival, and it should not delay or replace oncology treatment.